glyceraldehyde 3-phosphate has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amrich, CG; Celotto, AM; Larsen, SB; Palladino, MJ; Roland, BP; Stuchul, KA; Vandemark, AP | 1 |
| Date, I; Liu, K; Maruo, T; Mori, S; Nishibori, M; Ohtsuka, A; Okuma, Y; Otani, N; Shima, K; Takahashi, HK; Tomura, S; Wake, H; Yamamoto, H; Yamamoto, Y; Yoshino, T; Zhang, J | 1 |
| Arias, C; Massieu, L; Montiel, T; Quiroz-Baez, R | 1 |
3 other study(ies) available for glyceraldehyde 3-phosphate and Disease Models, Animal
| Article | Year |
|---|---|
Evidence of a triosephosphate isomerase non-catalytic function crucial to behavior and longevity.
Topics: Anemia, Hemolytic, Congenital Nonspherocytic; Animals; Carbohydrate Metabolism, Inborn Errors; Catalysis; Dihydroxyacetone Phosphate; Disease Models, Animal; Drosophila melanogaster; Female; Gene Knockout Techniques; Genetic Complementation Test; Genetic Engineering; Glyceraldehyde 3-Phosphate; Glycolysis; Hot Temperature; Longevity; Male; Mutation; Paralysis; Stress, Physiological; Transgenes; Triose-Phosphate Isomerase | 2013 |
Anti-high mobility group box-1 antibody therapy for traumatic brain injury.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries; Cell Death; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Evans Blue; Functional Laterality; Gene Expression Regulation; Glycation End Products, Advanced; Glyceraldehyde 3-Phosphate; HMGB1 Protein; Hypoxia-Inducible Factor 1; Immunoglobulin G; Magnetic Resonance Imaging; Male; Mice; Mice, Knockout; Microscopy, Electron, Transmission; Microtubule-Associated Proteins; Motor Activity; Neurons; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Rotarod Performance Test; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2012 |
Role of oxidative stress on beta-amyloid neurotoxicity elicited during impairment of energy metabolism in the hippocampus: protection by antioxidants.
Topics: Adenosine Triphosphate; Amyloid beta-Peptides; Animals; Disease Models, Animal; Drug Interactions; Energy Metabolism; Glyceraldehyde 3-Phosphate; Hippocampus; In Vitro Techniques; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Peptide Fragments; Rats; Succinate Dehydrogenase; Vitamin E | 2006 |